Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor
申请人:Sekiguchi Yoshinori
公开号:US20080090863A1
公开(公告)日:2008-04-17
The present invention encompasses novel substituted pyridine compounds of Formula (I):
which act as MCH receptor antagonists. These compositions and pharmaceutical compositions thereof are useful in the prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.
本发明涵盖了式(I)的新型取代吡啶化合物,其作为MCH受体拮抗剂。这些组合物及其制药组合物在预防或治疗改善记忆功能、睡眠和觉醒、焦虑、抑郁、情绪障碍、癫痫、肥胖症、糖尿病、食欲和饮食障碍、心血管疾病、高血压、血脂异常、心肌梗死、暴食障碍,包括贪食症、厌食症、精神障碍,包括躁郁症、精神分裂症、谵妄、痴呆、压力、认知障碍、注意力缺陷障碍、物质滥用障碍和运动障碍,包括帕金森病、癫痫和成瘾方面具有用处。